Gilead has chosen a partner for…
Gilead has chosen a partner for lenacapavir in the race [...]
Takeda tightened its pipeline in…
Takeda tightened its pipeline in the third quarter. Innovent Biologics [...]
Steven Hatfill, a senior advisor…
Steven Hatfill, a senior advisor for biosecurity at the Department [...]
Eli Lilly has halted development…
Eli Lilly has halted development of a phase 2 P2X7 [...]
Bristol Myers Squibb is shedding…
Bristol Myers Squibb is shedding two clinical programs from its [...]
Inflammation biotech Evommune…
Inflammation biotech Evommune plans to take the leap into public [...]
As Biogen continues to carve out…
As Biogen continues to carve out new markets for its [...]
With vaccine sales on the decline…
With vaccine sales on the decline across the industry, these [...]
Bristol Myers Squibb’s highly…
Bristol Myers Squibb’s highly anticipated Cobenfy just finished its first [...]
Sensei Biotherapeutics is…
Sensei Biotherapeutics is abandoning its sole clinical-stage drug and warning [...]